Illumina Inc.

ILMN-Q

NASDAQ:ILMN

263.50
9.49 (3.48%)
Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function.
More at Wikipedia

Analysis and Opinions about ILMN-Q

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
January 27, 2020

(A Top Pick Sep 12/19, Up 6%) The sector is interesting, though he sold Illumina, because the holding got too big. They supply testing machines for mines, which creates recurring revenues. Stick with it.

Show full opinionHide full opinion
Illumina Inc. (ILMN-Q)
January 27, 2020

(A Top Pick Sep 12/19, Up 6%) The sector is interesting, though he sold Illumina, because the holding got too big. They supply testing machines for mines, which creates recurring revenues. Stick with it.

TOP PICK
TOP PICK
September 12, 2019
They are a provider of sequencing solutions for genetic analysis. It is a really good entry level. It is a pretty volatile stock. Commercial genetic testing is going to explode and these guys are emphasizing consumables. (Analysts’ price target is $321.79)
Show full opinionHide full opinion
Illumina Inc. (ILMN-Q)
September 12, 2019
They are a provider of sequencing solutions for genetic analysis. It is a really good entry level. It is a pretty volatile stock. Commercial genetic testing is going to explode and these guys are emphasizing consumables. (Analysts’ price target is $321.79)
PAST TOP PICK
PAST TOP PICK
June 27, 2019
(A Top Pick Jul 18/18, Up 15%) They analyze genetic material. We are in the early stages of doing this for a whole host of applications. They are a generation ahead of competitors. This is a technology that is still relatively new.
Show full opinionHide full opinion
(A Top Pick Jul 18/18, Up 15%) They analyze genetic material. We are in the early stages of doing this for a whole host of applications. They are a generation ahead of competitors. This is a technology that is still relatively new.
TOP PICK
TOP PICK
June 5, 2019
The DNA revolution has recently started. DNA sequencing has come from the thousands of dollars to the hundreds making it ore retail. Fast growing US name. (Analysts’ price target is $345.93)
Show full opinionHide full opinion
The DNA revolution has recently started. DNA sequencing has come from the thousands of dollars to the hundreds making it ore retail. Fast growing US name. (Analysts’ price target is $345.93)
TOP PICK
TOP PICK
July 18, 2018

He is a big believer in disrupter companies in growth sectors. This is the only company in the world that can do high volume DNA sequencing. They already have a million customers and another million order backlog. There is no one else in this space. They sell equipment and the supplies to operate the equipment. Countries will have more DNA sequencing done to help new drug development. Yield 0%. (Analysts’ price target is $286.06)

Show full opinionHide full opinion

He is a big believer in disrupter companies in growth sectors. This is the only company in the world that can do high volume DNA sequencing. They already have a million customers and another million order backlog. There is no one else in this space. They sell equipment and the supplies to operate the equipment. Countries will have more DNA sequencing done to help new drug development. Yield 0%. (Analysts’ price target is $286.06)

COMMENT
COMMENT
October 28, 2013

Dominant player in gene sequencing business. Becoming more commercially available to clinics instead of just research labs. They are buying up some of their customers and going into competition with them. He is nervous of the valuation. It is at and beyond his expectations.

Show full opinionHide full opinion
Illumina Inc. (ILMN-Q)
October 28, 2013

Dominant player in gene sequencing business. Becoming more commercially available to clinics instead of just research labs. They are buying up some of their customers and going into competition with them. He is nervous of the valuation. It is at and beyond his expectations.

Showing 1 to 6 of 6 entries
  • «
  • 1
  • »

Illumina Inc.(ILMN-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Illumina Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Illumina Inc.(ILMN-Q) Frequently Asked Questions

What is Illumina Inc. stock symbol?

Illumina Inc. is a American stock, trading under the symbol ILMN-Q on the NASDAQ (ILMN). It is usually referred to as NASDAQ:ILMN or ILMN-Q

Is Illumina Inc. a buy or a sell?

In the last year, 2 stock analyst published opinions about ILMN-Q. 2 analyst recommended to BUY the stock. 0 analyst recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for Illumina Inc..

Is Illumina Inc. a good investment or a top pick?

Illumina Inc. was recommended as a Top Pick by Hap (Robert) Sneddon FCSI on 2020-01-27. Read the latest stock experts ratings for Illumina Inc..

Why is Illumina Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Illumina Inc. worth watching?

2 stock analyst on Stockchase covered Illumina Inc. In the last year. It is a trending stock that is worth watching.

What is Illumina Inc. stock price?

On 2020-04-03, Illumina Inc. (ILMN-Q) stock closed at a price of $263.5.